IBB icon

iShares Biotechnology ETF

428 hedge funds and large institutions have $3.72B invested in iShares Biotechnology ETF in 2016 Q2 according to their latest regulatory filings, with 71 funds opening new positions, 149 increasing their positions, 122 reducing their positions, and 52 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
428
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
20
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$629M
Puts
$1.39B
Net Calls
Net Calls Change

Top Buyers

1 +$130M
2 +$127M
3 +$79.5M
4
Citadel Advisors
Citadel Advisors
Florida
+$50.6M
5
SG Americas Securities
SG Americas Securities
New York
+$45.3M

Top Sellers

1 -$157M
2 -$142M
3 -$128M
4
LPL Financial
LPL Financial
California
-$71M
5
Jane Street
Jane Street
New York
-$69.1M
Name Holding Trade Value Shares
Change
Change in
Stake
151
$1.64M
152
$1.62M
153
$1.54M
154
$1.54M
155
$1.54M
156
$1.53M
157
$1.5M
158
$1.5M
159
$1.49M
160
$1.48M
161
$1.46M
162
$1.46M
163
$1.44M
164
$1.43M
165
$1.41M
166
$1.37M
167
$1.36M
168
$1.29M
169
$1.28M
170
$1.27M
171
$1.2M
172
$1.18M
173
$1.18M
174
$1.17M
175
$1.17M